Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes.
Saleem U, van Meer BJ, Katili PA, Mohd Yusof NAN, Mannhardt I, Garcia AK, Tertoolen L, de Korte T, Vlaming MLH, McGlynn K, Nebel J, Bahinski A, Harris K, Rossman E, Xu X, Burton FL, Smith GL, Clements P, Mummery CL, Eschenhagen T, Hansen A, Denning C. Saleem U, et al. Among authors: eschenhagen t. Toxicol Sci. 2020 Jul 1;176(1):103-123. doi: 10.1093/toxsci/kfaa058. Toxicol Sci. 2020. PMID: 32421822 Free PMC article.
Development of a drug screening platform based on engineered heart tissue.
Hansen A, Eder A, Bönstrup M, Flato M, Mewe M, Schaaf S, Aksehirlioglu B, Schwoerer AP, Uebeler J, Eschenhagen T. Hansen A, et al. Among authors: eschenhagen t. Circ Res. 2010 Jul 9;107(1):35-44. doi: 10.1161/CIRCRESAHA.109.211458. Epub 2010 May 6. Circ Res. 2010. PMID: 20448218
[Sorafenib].
Hansen A, Eschenhagen T. Hansen A, et al. Among authors: eschenhagen t. Dtsch Med Wochenschr. 2010 Sep;135(37):1819-22. doi: 10.1055/s-0030-1247869. Epub 2010 Aug 20. Dtsch Med Wochenschr. 2010. PMID: 20730706 German. No abstract available.
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, Müller OJ, McGrath MJ, Vollert I, Hansen A, Linke WA, Hengstenberg C, Bonne G, Morner S, Wichter T, Madeira H, Arbustini E, Eschenhagen T, Mitchell CA, Isnard R, Carrier L. Friedrich FW, et al. Among authors: eschenhagen t. Hum Mol Genet. 2012 Jul 15;21(14):3237-54. doi: 10.1093/hmg/dds157. Epub 2012 Apr 20. Hum Mol Genet. 2012. PMID: 22523091
Physiological aspects of cardiac tissue engineering.
Eschenhagen T, Eder A, Vollert I, Hansen A. Eschenhagen T, et al. Am J Physiol Heart Circ Physiol. 2012 Jul 15;303(2):H133-43. doi: 10.1152/ajpheart.00007.2012. Epub 2012 May 11. Am J Physiol Heart Circ Physiol. 2012. PMID: 22582087 Free article. Review.
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.
Hirt MN, Sörensen NA, Bartholdt LM, Boeddinghaus J, Schaaf S, Eder A, Vollert I, Stöhr A, Schulze T, Witten A, Stoll M, Hansen A, Eschenhagen T. Hirt MN, et al. Among authors: eschenhagen t. Basic Res Cardiol. 2012 Nov;107(6):307. doi: 10.1007/s00395-012-0307-z. Epub 2012 Oct 26. Basic Res Cardiol. 2012. PMID: 23099820 Free PMC article.
In vitro perfusion of engineered heart tissue through endothelialized channels.
Vollert I, Seiffert M, Bachmair J, Sander M, Eder A, Conradi L, Vogelsang A, Schulze T, Uebeler J, Holnthoner W, Redl H, Reichenspurner H, Hansen A, Eschenhagen T. Vollert I, et al. Among authors: eschenhagen t. Tissue Eng Part A. 2014 Feb;20(3-4):854-63. doi: 10.1089/ten.TEA.2013.0214. Epub 2013 Dec 11. Tissue Eng Part A. 2014. PMID: 24156346
394 results